Perfusion by Arterial Spin Labelling Following Single Dose Tadalafil in Small Vessel Disease (PASTIS) Trial (PASTIS)
Sponsor: Alzheimer's Drug Discovery Foundation
This PHASE2 trial investigates Dementia, Vascular and is currently completed. Alzheimer's Drug Discovery Foundation leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Nov 2022 — Jul 2024 [monthly]
Completed PHASE2
Status: Unknown Status → Completed
-
Jan 2021 — Nov 2022 [monthly]
Unknown Status PHASE2
-
Sep 2020 — Jan 2021 [monthly]
Unknown Status PHASE2
Status: Active Not Recruiting → Unknown Status
▶ Show 3 earlier versions
-
Sep 2018 — Sep 2020 [monthly]
Active Not Recruiting PHASE2
-
Jun 2018 — Sep 2018 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE2
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Alzheimer's Drug Discovery Foundation
- Alzheimer's Society
- St George's University Hospitals NHS Foundation Trust
- St George's, University of London
- University of Copenhagen
- University of Glasgow
For direct contact, visit the study record on ClinicalTrials.gov .